Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 4

Results For "New-Zealand"

40 News Found

Wipro GE Healthcare bolsters leadership bench in India & South Asia
People | March 23, 2022

Wipro GE Healthcare bolsters leadership bench in India & South Asia

This announcement comes after the formation of a new Intercontinental Region within GE Healthcare, led by Chaillot


Scientists breaking barriers to treating heart failure
Medical Device | February 09, 2022

Scientists breaking barriers to treating heart failure

Cysoni is a bionic device that paces the heart with real-time respiratory modulation. The innovation stems from the idea that heart rate increases and decreases with each breath in normal physiology, termed ‘respiratory sinus arrhythmia’ (RSA)


Biocon consolidated PAT at Rs 187.1 cr. in Q3FY22
News | January 21, 2022

Biocon consolidated PAT at Rs 187.1 cr. in Q3FY22

Biocon has reported consolidated financial results for the period ended December 31, 2021


Barentz appoints Daniel Hitz as CEO, APAC
People | January 07, 2022

Barentz appoints Daniel Hitz as CEO, APAC

Hitz shall assume new role from January 17th, 2022


Morpen gets U.S. FDA approval for Fexofinadine
Drug Approval | December 05, 2021

Morpen gets U.S. FDA approval for Fexofinadine

Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever


Pfizer seeks EUA from U.S. FDA for Covid-19 drug
Biotech | November 17, 2021

Pfizer seeks EUA from U.S. FDA for Covid-19 drug

If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2


Novavax files for approval of its Covid-19 vaccine in the UK
Biotech | October 27, 2021

Novavax files for approval of its Covid-19 vaccine in the UK

Filing marks first protein-based vaccine submitted to MHRA for authorization


Cigna sells its life, accident and allied businesses to Chubb for US $ 5.75 billion
Healthcare | October 08, 2021

Cigna sells its life, accident and allied businesses to Chubb for US $ 5.75 billion

The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio


ResMed acquires home sleep testing company Ectosense
Startup | October 05, 2021

ResMed acquires home sleep testing company Ectosense

Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test


GSK files application for MMR vaccine in the US
News | August 11, 2021

GSK files application for MMR vaccine in the US

If approved it will bring a second source of MMR vaccine to the US market